◀ Back to NPY

AVP — NPY

Text-mined interactions from Literome

Wren et al., Neuroendocrinology 2002 : Ghrelin ( 10, 100 and 1,000 nM ) stimulated the release of both corticotropin releasing hormone (CRH) ( 100 nM : 6.0 +/- 0.8 vs. basal 4.2 +/- 0.5 pmol/explant, n = 49, p < 0.05 ) and arginine vasopressin (AVP) ( 100 nM : 49.2 +/- 5.9 vs. basal 35.0 +/- 3.3 fmol/explant, n = 48, p < 0.05 ), whilst ghrelin ( 100 and 1,000 nM ) also stimulated the release of neuropeptide Y (NPY) ( 100 nM : 111.4 +/- 25.0 vs. basal 54.4 +/- 9.0 fmol/explant, n = 26, p < 0.05 ) from hypothalamic explants in vitro
Aoyagi et al., Eur J Pharmacol 2009 : Here, we further study the involvement of the AVP/V ( 1A ) receptor in the appetite regulation of neuropeptide Y with V(1A)R ( -/- ) mice and antagonists for the AVP receptor
Liu et al., J Clin Invest 1994 (Cushing Syndrome) : NPY ( 50 microgram ) also increased mean CRF and AVP levels ( 1 h, 1.4- and 4.2-fold ; 4 h, 1.1- and 1.9-fold ), increased pituitary-adrenal activity at 1 h, and caused ACTH hypersecretion at 4 h